Semi-Annual Consolidated Statement Of Comprehensive Income

Fuji Pharma Co.,Ltd. - Filing #7264782

Concept 2024-10-01 to
2025-03-31
2023-10-01 to
2024-03-31
Semi-annual consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
1,287,000,000 JPY
4,257,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-730,000,000 JPY
-1,090,000,000 JPY
Deferred gains or losses on hedges
1,000,000 JPY
42,000,000 JPY
Foreign currency translation adjustment
-26,000,000 JPY
142,000,000 JPY
Remeasurements of defined benefit plans, net of tax
8,000,000 JPY
-3,000,000 JPY
Other comprehensive income
-746,000,000 JPY
-908,000,000 JPY
Comprehensive income
540,000,000 JPY
3,349,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
540,000,000 JPY
3,349,000,000 JPY
Comprehensive income attributable to non-controlling interests
0 JPY
0 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.